Apoptosis: Basic concepts and implications in coronary artery disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 1, 1999, Pages 14-22

  Best, Patricia J M ^a   Hasdai, David ^a   Sangiorgi, Giuseppe ^a   Schwartz, Robert S ^a   Holmes Jr , David R ^a   Simari, Robert D ^b   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Apoptosis; Atherosclerosis; Cell death; Coronary disease; Restenosis

Indexed keywords

ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; CASPASE; CERAMIDE; ENDOTHELIN 1; NATRIURETIC PEPTIDE TYPE C; NITRIC OXIDE; PROTEIN P53;

APOPTOSIS; ARTERY CONSTRICTION; ARTERY INTIMA PROLIFERATION; ATHEROGENESIS; CORONARY ARTERY ATHEROSCLEROSIS; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; VASCULAR SMOOTH MUSCLE;

EID: 0032941192     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.1.14     Document Type: Review

References (84)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biologic phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-257.
2. Wyllie AH, Arends MJ, Morris RG, Walker SW, Evan G. The apoptosis endonuclease and its regulation. Semin Immunol. 1992;4:389-397.
3. Rowan S, Fisher DE. Mechanisms of apoptotic cell death. Leukemia. 1997;11:457-465.
4. Sachs L. The control of hematopoiesis and leukemia: from basic biology to the clinic. Proc Natl Acad Sci U S A. 1996;93:4742-4749.
5. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol. 1995;11: 73-91.
6. Haanen C, Vermes I. Apoptosis: programmed cell death in fetal development. Eur J Obstet Gynecol Reprod Biol. 1996;64:129-133.
7. Ellis PA, Smith IE, Dowsett M. Apoptosis: its role in tumour growth and therapy. Cytopathology. 1996;7:201-203.
8. Ameisen JC. Programmed cell death (apoptosis) and cell survival regulation: relevance to AIDS and cancer. AIDS. 1994;8:1197-1213.
9. Yao M, Keogh A, Spratt P, dos Remedios CG, Kiessling PC. Elevated DNase I levels in human idiopathic dilated cardiomyopathy: an indicator of apoptosis? J Mol Cell Cardiol. 1996;28:95-101.
10. Cheng W, Kajstura J, Nitahara JA, Li B, Reiss K, Liu Y, Clark WA, Krajewski S, Reed JC, Olivetti G, Anversa P. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res. 1996;226:316-327.
11. Mallat Z, Tedgui A, Fontaliran F, Frank R, Duigon M, Fontaine G. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med. 1996;335:1190-1196.
12. James TN. Long reflections on the QT interval: the sixth annual Gordon K. Moe Lecture. J Cardiovasc Electrophysiol. 1996;7:738-759.
13. James TN, St Martin E, Willis PW 3rd, Lohr TO. Apoptosis as a possible cause of gradual development of complete heart block and fatal arrhythmias associated with absence of the AV node, sinus node, and internodal pathways. Circulation. 1996;93:1424-1438.
14. Geng YJ, Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1β-converting enzyme. Am J Pathol. 1995;147:251-266.
15. Bochaton-Piallat ML, Gabbiani F, Redard M, Desmouliere A, Gabbiani G. Apoptosis participates in cellular regulation during rat aortic intimai thickening. Am J Pathol. 1995;146:1059-1064.
16. Dong C, Wilson JE, Winters GL, McManus BM. Human transplant coronary artery disease: pathologic evidence for Fas mediated apoptotic cytotoxicity in allograft arteriopathy. Lab Invest. 1996:74:921-931.
17. Mallat Z, Ohan J, Leseche G, Tedgui A. Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques. Circulation. 1997;96: 424-428.
18. Fukuo K, Hata S, Suhara T, Nakahashi T, Shinto Y, Tsujimoto Y, Morimoto S, Ogihara T. Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension. 1996;27:823-826.
19. Pollman MJ, Yamada T, Horiuchi M, Gibbons GH. Vasoactive substances regulate vascular smooth muscle cell apoptosis. Circ Res. 1996; 79:748-756.
20. Shichiri M, Kato H, Marumo F, Hirata Y. Endothelin-1 as an autocrine/ paracrine apoptosis survival factor for endothelial cells. Hypertension. 1997;30:1198-1203.
21. Dimmeler S, Rippmann V, Weiland U, Haendeler J, Zeiher AM. Angiotensin II induces apoptosis of human endothelial cells: protective effect of nitric oxide. Circ Res. 1997;81:970-976.
22. Sharifi AM, Schriffrin EL. Apoptosis in aorta of deoxycorticosterone acetate-salt hypertensive rats: effects of endothelin receptor antagonism. J Hypertens. 1997;15(pt 1):1441-1448.
23. Kerr JFR. A histochemical study of hypertrophy and ischaemic injury of rat liver with special references to changes in lysosomes. J Pathol Bacteriol. 1965;90:419-435.
24. Majno G, Joris I. Apoptosis. oncosis, and necrosis. an overview of cell death. Am J Pathol. 1995;146:3-15.
25. Kerr JFR, Gobé GC, Winterford CM, Harmon BV. Anatomic methods in cell death. Methods Cell Biol. 1995;46:1-27.
26. Crompton T, Peitsch MC, MacDonald HR, Tschopp J. Propidium iodide staining correlates with the extent of DNA degradation in isolated nuclei. Biochem Biophys Res Commun. 1992;183:532-537.
27. Tounekti O, Belehradek J Jr, Mir LM. Relationship between DNA fragmentation, chromatin condensation, and changes in flow cytometry profiles detected during apoptosis. Exp Cell Res. 1995;217:506-516.
28. Kimura K, Sasano H, Shimosegawa T, Kato K, Noguchi T, Mochizuki S, Sawai T, Koizumi M, Totyota T, Nagura H. Ultrastructural and confocal laser scanning microscopic examination of TUNEL-positive cells. J Pathol. 1997;181:235-242.
29. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in-situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
30. Kockx MM, De Meyer GRY, Muhring J, Bult H, Bultinck J, Herman AG. Distribution of cell replication and apoptosis in atherosclerotic plaque of cholesterol-fed rabbits. Atherosclerosis. 1996;120:115-124.
31. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology. 1995;21:1465-1468.
32. Charriaut-Marlangue C, Ben-Ari Y. A cautionary note on the use of the TUNEL stain to determine apoptosis. Neuroreport. 1995;7:61-64.
33. Marini M, Musiani D, Sestili P, Cantoni O. Apoptosis of human lymphocytes in the absence or presence of internucleosomal DNA cleavage. Biochem Biophys Res Commun. 1996;229:910-915.
34. Cohen GM, Sun XM, Snowden RT, Dinsdale D, Skilleter DN. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J. 1992;286(pt 2):331-334.
35. Samaha H, Berstein C, Payne C, Asher E. Evaluation of cell death in EBV-transformed lymphocytes using agarose gel electrophoresis: light microscopy and electron microscopy, I: induction of classic apoptosis by the bile salt, sodium deoxycholate. Leuk Lymphoma. 1995;19:95-105.
36. Peitsch MC, Polzar B, Stephan H, Crompton T, MacDonald HR, Mannerherz HG, Tschopp J. Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J. 1993;12:371-377.
37. Franker PJ, King LE, Lill-Elghanian D, Telford WG. Quantification of apoptotic events in pure and heterogeneous populations of cells using the flow cytometer. Methods Cell Biol 1995;46:57-76.
38. Carbonari M, Cibati M, Fiorilli M. Measurement of apoptotic cells in peripheral blood. Cytometry. 1995;22:161-167.
39. Mesner PW Jr, Kaufmann SH. Methods utilized in the study of apoptosis. Adv Pharmacol. 1997;41:57-87.
40. Telford WG, King LE, Franker PJ. Evaluation of glucocorticoid-induced DNA fragmentation in thymocytes by flow cytometry. Cell Prolif. 1991; 24:447-459.
41. Sherwood SW, Schimke RT. Cell cycle analysis of apoptosis using flow cytometry. Methods Cell Biol. 1995;46:77-97.
42. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456-1462.
43. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995;95:2266-2274.
44. Nagata S, Golstein P. The Fas death factor. Science. 1995;267: 1449-1456.
45. Wantanabe-Fukunaga R, Brannan CI, Copland NG, Jenkins NA, Nagata S. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992;356:314-317.
46. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 1994;76:969-976.
47. Alderson MR, Armitage RJ, Marakovsky E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch DH. Fas transduces activation signals in normal human T lymphocytes. J Exp Med. 1993;178:2231-2235.
48. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R. Ceramide synthase mediates daunorubacin-induced apoptosis: a new mechanism for generating death signals. Cell. 1995;82:405-414.
49. Evan G, Wyllie A, Gilbert C, Littlewood T, Land H, Brooks M, Walters C, Penn L, Hancock D. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 1992;63:119-125.
50. Desbarats L, Schneider A, Muller D, Burgin A, Eilers M. Myc: a single gene controls both proliferation and apoptosis in mammalian cells links external signals to cell cycle machinery. Experientia. 1996;52: 1123-1129.
51. Miura M, Zhu H, Rotello R, Hartwig EA, Yuan J. Induction of apoptosis in fibroblasts by IL-1 β-converting enzyme, a mammalian homologue of the C. elegans cell death gene ced-3. Cell. 1993;75:653-660.
52. Zhu H, Fearnhead HO, Cohen GM. An ICE-like protease is a common mediator of apoptosis induced by diverse stimuli in human monocytic THP 1 cells. FEBS Lett. 1995;374:303-308.
53. Boudreau N, Sympson CJ, Werb Z, Bissell MJ. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science. 1995;267:891-893.
54. Tewardi M, Dixit VM. Fas-and tumor necrosis factor-induced apoptosis is inhibited by poxvirus crmA gene product. J Biol Chem. 1995;270: 3255-3260.
55. Miuri M, Friedlander RM, Yuan J. Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. Proc Natl Acad Sci U S A. 1995;92:8318-8322.
56. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature. 1993;361:365-369.
57. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol. 1994;124:1-6.
58. Hockenbery DM. The bcl-2 gene and apoptosis. Semin Immunol. 1992; 4:413-420.
59. Reed JC, Cuddy M, Slabiak T, Croce CM, Nowell PC. Oncogenic potential of bcl-2 demonstrated by gene transfer. Nature. 1988;336: 259-261.
60. Takayama S, Cazals-Hatem DL, Kitada S, Tanaka S, Miyashi T, Hovey LR, Huen D, Rickinson A, Veerapandian P, Krajewski S, Saito K, Reed JC. Evolutionary conservation of function among mammalian, avian, and viral homologues of the bcl-2 oncoprotein: structure-function implications. DNA Cell Biol. 1994;13:679-692.
61. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB. BCL-x, a bcl-2 related gene that functions as a dominant receptor of apoptotic cell death. Cell. 1993;74:597-608.
62. Schwartz SM, Bennett MR. Death by another name. Am J Pathol. 1995; 147:229-234.
63. Bjorkerud S, Bjorkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol. 1996;149:367-380.
64. Perlman H, Maillard L, Krasinski K, Walsh K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation. 1997;95:981-987.
65. Man DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat model vascular injury model. Am J Pathol. 1995;147:267-277.
66. Richardson BC, Lalwani ND, Johnson KJ, Marks RM. Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur J Immunol. 1994;24:2640-2645.
67. Fox JC, Shanley JR. Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells. J Biol Chem. 1996; 271:12578-12584.
68. Kockx MM, Muhring J, Bortier H, De Meyer GRY, Jacob W. Biotin-or digoxigenin-conjugated nucleosides bind to matrix vesicles in atherosclerotic plaques. Am J Pathol. 1996;148:1771-1777.
69. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 1995;91:2703-2711.
70. Kollum M, Kaiser S, Kinscherf R, Metz J, Kubler W, Hehrlein C. Apoptosis after stent implantation compared with balloon angioplasty in rabbits: role of macrophages. Arterioscler Thromb Vasc Biol. 1997;17: 2383-2388.
71. Kockx MM, De Meyer GRY, Bortier H, de Meyere N, Muhring J, Bakker A, Jacob W, Van Vaeck L, Herman A. Luminal foam cell accumulation is associated with smooth muscle cell death in the intimai thickening of human saphenous vein grafts. Circulation. 1996;94:1255-1262.
72. Yamori Y, Igawa T, Kanbe T, Kihara M, Naara M, Naara Y, Horie R. Mechanisms of structural vascular changes in genetic hypertension: analyses on culture vascular smooth muscle cells from spontaneously hypertensive rats. Clin Sci. 1981;61:121S-123S.
73. Hamet P, Richard L, Dam TV, Teiger E, Orlov SN, Gaboury L, Gossard F, Tremblay J. Apoptosis in target organs of hypertension. Hypertension. 1995;26:642-648.
74. Caceres-Cortes J, Rajotte D, Dumouchel J, Haddad P, Hoang T. Product of the steel locus suppress apoptosis in hematopoietic cells: comparison with pathways activated by granulocyte macrophage colony-stimulating factor. J Biol Chem. 1994;269:12084-12091.
75. Hamet P. Proliferation and apoptosis of the vascular smooth muscle in hypertension. Curr Opin Nephrol Hypertens. 1995;4:1-7.
76. Jackson CL, Schwartz SM. Pharmacology of smooth muscle cell replication. Hypertension. 1992;20:713-736.
77. deBlois D, Tea BS, Than VD, Tremblay J, Hamet P. Smooth muscle cell apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension. 1997;29(pt 2):340-349.
78. Imai H, Werthessen NT, Subramayam V, Lequesne PW, Soloway AH, Kanisawa M. Angiotoxicity of oxygenates sterols and possible precursors. Science. 1980;207:651-653.
79. Lizard G, Decken V, Dubrez L, Moisant M, Gambert P, Lagrost L. Induction of apoptosis in endothelial cells treated with cholesterol oxides. Am J Pathol. 1996;148:1625-1638.
80. Palladini G, Finardi G, Bellomo G. Disruption of actin microfilament organization by cholesterol oxides in 73/73 endothelial cells. Exp Cell Res. 1996;223:72-82.
81. Dimmeler S, Haendeler J, Galle J, Zeiher AM. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like protease. Circulation. 1997;95:1760-1763.
82. Song Q, Wei T, Lees-Miller S, Alnemri E, Watters D, Lavin MF. Resistance of actin to cleavage during apoptosis. Proc Natl Acad Sci USA. 1997;94:157-162.
83. Nishio E, Fukuahima K, Shiozaki M, Watanabe Y. Nitric oxide donor SNAP induces apoptosis in smooth muscle cells through cGMP-independent mechanism. Biochem Biophys Res Commun. 1996;221: 163-168.
84. Trindade P, Hutchinson HG, Pollman MJ, Gibbons GH, Pratt RE. Atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) induce apoptosis in vascular smooth muscle cells (VSMC). Circulation. 1995; 92(suppl I):I-696. Abstract.